Nephritis vs nephrotic syndrome

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have comprehensive material from multiple authoritative nephrology and pathology textbooks. Here is a detailed comparison:

Nephritis (Nephritic Syndrome) vs Nephrotic Syndrome

Core Concept

Nephritic SyndromeNephrotic Syndrome
Primary lesionGlomerular inflammation → disrupted capillary wall integrityGlomerular permeability defect → protein leaks freely
Cell type affectedEndothelial/mesangial cells + infiltrating leukocytesPodocytes (visceral epithelial cells)
Pathologic patternProliferative, inflammatoryPodocytopathy; minimal/sclerosing/membranous changes

Clinical Features Compared

FeatureNephroticNephritic
OnsetInsidiousAbrupt
Edema++++ (massive, periorbital, pitting)++ (mild–moderate)
Blood pressureNormalRaised
Jugular venous pressureNormal/lowRaised
Proteinuria++++ (>3.5 g/day)++ (subnephrotic)
HematuriaMay/may not occur+++ (brown/cola urine)
RBC castsAbsentPresent
Serum albuminLow (<3 g/dL)Normal or slightly reduced
GFR/AzotemiaPreserved earlyReduced (oliguria, azotemia)
Comprehensive Clinical Nephrology, 7th Ed., Table 16.4

Pathophysiology

Nephritic Syndrome

  • Immune-mediated inflammation → proliferation of glomerular cells + leukocyte infiltration
  • Severely injures capillary walls → RBCs escape into urine (hematuria, RBC casts)
  • Hemodynamic changes → reduced GFR → oliguria, fluid retention, azotemia
  • Hypertension from fluid overload + renin release from ischemic kidneys

Nephrotic Syndrome

  • Increased GBM permeability + slit diaphragm disruption (podocyte injury)
  • Massive proteinuria → hypoalbuminemia → reduced plasma oncotic pressure → edema
  • Secondary aldosterone/sympathetic activation → further Na⁺/water retention
  • Hyperlipidemia and lipiduria: liver upregulates lipoprotein synthesis to compensate for low oncotic pressure
  • Loss of antithrombin III, protein C/S → thromboembolism risk (DVT, renal vein thrombosis in 10–40%)
  • Loss of immunoglobulins → infection susceptibility
Robbins & Cotran Pathologic Basis of Disease; Tietz Textbook of Laboratory Medicine, 7th Ed.

Urine Sediment

NephriticNephrotic
CastsRBC casts (pathognomonic)Fatty casts, oval fat bodies
RBCsDysmorphic RBCsRare
ProteinModerateMassive (>3.5 g/day)
AppearanceSmoky/brown ("Coca-Cola urine")Frothy

Causes

Nephritic Syndrome

  • Postinfectious GN (post-streptococcal — most classic; types 1, 4, 12 group A β-hemolytic strep)
  • IgA nephropathy (Berger disease)
  • Rapidly progressive GN (RPGN/crescentic GN) — anti-GBM (Goodpasture), immune complex, ANCA-associated
  • Lupus nephritis (proliferative forms)
  • Membranoproliferative GN (can overlap with nephrotic)

Nephrotic Syndrome

DiseaseAge GroupNotes
Minimal Change Disease (MCD)Children (most common)Podocyte foot process effacement only on EM
Focal Segmental Glomerulosclerosis (FSGS)Adults (most common primary)Can be HIV-related (collapsing FSGS)
Membranous NephropathyAdultsPLA2R antibody; 2° causes: HBV, malignancy
Diabetic nephropathyAdultsSecondary; most common overall
AmyloidosisOlder adultsCongo red positive
Lupus nephritis (membranous type)WomenSecondary

Key Complications

ComplicationNephroticNephritic
Thromboembolism✓✓ (loss of antithrombin III)Less common
Infection✓ (loss of IgG, complement)Less common
Hyperlipidemia / atherosclerosis✓✓
AKI / kidney failureCan occur (FSGS, MCD in elderly)✓ (RPGN can cause rapid loss)
Hypertensive emergency

Memory Hooks

  • NephrItic = Inflammation → Injured vessels → blood in urine (hematuria, RBC casts, hypertension)
  • NephrOtic = Oozing protein → Oedema, hypOalbuminemia, hyperlipidemia
Note: Some diseases (e.g., membranoproliferative GN, lupus nephritis) can present with overlap of both syndromes — the two are not always mutually exclusive.
Comprehensive Clinical Nephrology, 7th Ed.; Robbins & Cotran Pathologic Basis of Disease; Tietz Textbook of Laboratory Medicine, 7th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.